Form F-6 - Registration of American Depository Receipt shares, not immediately effective:
SEC Accession No. 0001193805-20-000892
Filing Date
2020-07-27
Accepted
2020-07-27 17:16:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 e619803_f6-freeline.htm F-6 56492
2 e619803_ex99-a.htm EX-99.(A) 458475
3 e619803_ex99-d.htm EX-99.(D) 6536
4 GRAPHIC logo.jpg GRAPHIC 18700
  Complete submission text file 0001193805-20-000892.txt   549084
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

EIN.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6

Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Subject) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6 | Act: 33 | File No.: 333-240125 | Film No.: 201051132
SIC: 2836 Biological Products, (No Diagnostic Substances)